| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
| (30) |
Priority: |
14.01.2003 US 440009 P
|
| (43) |
Date of publication of application: |
|
16.11.2005 Bulletin 2005/46 |
| (60) |
Divisional application: |
|
12183770.2 / 2561887 |
| (73) |
Proprietor: Dana-Farber Cancer Institute, Inc. |
|
Boston, MA 02115-5450 (US) |
|
| (72) |
Inventors: |
|
- TAI, Isabelle, T.
Vancouver, B.C. V6Z 3A9 (CA)
- CHEN, Lan, Bo
Lexington, MA 02420 (US)
|
| (74) |
Representative: D Young & Co LLP |
|
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB) |
| (56) |
References cited: :
WO-A-02/089772
US-B1- 6 406 693
|
US-A1- 2003 082 228
US-B1- 6 475 784
|
|
| |
|
|
- G.K. YIU ET AL: "SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis
in Ovarian Cancer Cells" AMERICAN JOURNAL OF PATHOLOGY, vol. 159, no. 2, February
2001 (2001-02), pages 609-622, XP002983766
- I.A. CREE ET AL: "Chemosensitization of Solid Tumor Cells by Alteration of their Susceptibility
to Apoptosis" CURRENT OPINION IN INVESTIGATIONAL DRUGS, vol. 3, no. 4, April 2002
(2002-04), pages 641-647, XP008095641
- N. DHANESUAN ET AL: "Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in
MDA-MB-231 human breast cancer cells results in growth inhibition." BREAST CANCER
RESEARCH, vol. 75, no. 1, September 2002 (2002-09), pages 73-85, XP002493062
- U. STEIN ET AL: "Reversal of Multidrug Resistance by Transduction of Cytokine Genes
into Human Colon Carcinoma Cells" JOURNAL OF THE NATIONAL CANCER INSTITUTE, vol. 88,
no. 19, 2 October 1996 (1996-10-02), pages 1383-1392, XP002493063
- YIU G.K. ET AL: 'SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis
in Ovarian Cancer Cells' AM J PATHOL vol. 159, no. 2, August 2001, pages 609 - 662,
XP002983766
- CHLENSKI A. ET AL: 'SPARC Is a Key Schwannian-derived Inhibitor Controlling Neuroblastoma
Tumor Angiogenesis' CANCER RES vol. 62, 15 December 2002, pages 7357 - 7363, XP002986916
|
|
